How to manage hyponatremia (low sodium) and hypokalemia (low potassium) in a patient on hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia and Hypokalemia in Hemodialysis Patients

Hyponatremia Management

For hemodialysis patients with hyponatremia, use dialysate sodium concentration of 135-138 mEq/L and control the rate of sodium correction to 4-6 mEq/L per 24 hours (maximum 8-10 mEq/L in first 24 hours) to prevent osmotic demyelination syndrome while achieving volume and blood pressure control. 1, 2

Acute Correction Strategy for Severe Hyponatremia

  • Reduce blood flow rate to 50 mL/minute during initial hemodialysis sessions to slow sodium correction when serum sodium is severely low (e.g., <115 mEq/L). 3

  • Use dialysate sodium of 130-135 mEq/L for patients with severe hyponatremia, as this prevents excessively rapid correction that occurs with standard dialysate (140 mEq/L or higher). 2, 3

  • Monitor serum sodium every 2-4 hours during initial dialysis sessions to ensure correction rates remain within the safe 4-6 mEq/L per 24-hour target. 1

  • Minimize ultrafiltration volume during initial sessions, as aggressive fluid removal combined with sodium diffusion accelerates correction beyond safe limits. 2

  • For patients requiring both volume removal and controlled sodium correction, continuous venovenous hemofiltration with customized low-sodium replacement fluid allows precise control of correction rate through single-pool sodium kinetic modeling. 4, 5

Long-Term Maintenance Strategy

  • Maintain dialysate sodium at 135-138 mEq/L for ongoing treatments, as this range optimizes outcomes without promoting thirst or interdialytic weight gain. 1

  • Avoid dialysate sodium ≥140 mEq/L, which increases thirst, interdialytic weight gain, hypertension, and cardiovascular workload—all contributing to increased morbidity and mortality. 6, 1, 7, 2

  • Discourage sodium profiling (starting at 145-155 mEq/L and decreasing), as this technique produces the same adverse effects as sustained high dialysate sodium. 6, 2

Dietary and Fluid Management

  • Implement dietary sodium restriction to 2-3 g/day (85-100 mmol/day) to minimize interdialytic sodium accumulation and facilitate achievement of dry weight. 1, 2

  • Review fluid intake patterns, as excessive free water consumption between dialysis sessions is a common cause of hyponatremia in dialysis patients. 2

  • Limit fluid intake to 1-1.5 L/day if the patient is hypervolemic with persistent hyponatremia. 2

Critical Safety Monitoring

  • Continuously assess neurological status for signs of osmotic demyelination syndrome, including confusion, altered consciousness, seizures, or new neurological deficits. 1, 2

  • The lag phenomenon means that blood pressure normalization may take time despite proper volume control—do not interpret persistent hypertension as treatment failure during the initial correction phase. 6

Hypokalemia Management

For hemodialysis patients with hypokalemia, increase dialysate potassium concentration and provide oral potassium supplementation with controlled-release preparations, as hypokalemia in HD patients poses significant risks for cardiac arrhythmias and digitalis toxicity. 8, 9

Dialysate Potassium Adjustment

  • Increase dialysate potassium concentration to 3.0-4.0 mEq/L to prevent excessive potassium removal during dialysis sessions. 9

  • Standard hemodialysis removes 70-150 mmol of potassium per session through diffusion, and this removal is increased by glucose-free dialysate and sodium profiling. 9

Oral Potassium Supplementation

  • Use controlled-release potassium chloride preparations for patients who cannot tolerate or refuse liquid/effervescent preparations, though these should be reserved due to risks of intestinal and gastric ulceration. 8

  • Potassium supplementation is particularly critical for digitalized patients, those with significant cardiac arrhythmias, or patients with potassium-losing conditions. 8

Monitoring and Prevention

  • Check serum potassium periodically between dialysis sessions to guide supplementation needs. 8

  • Review medications that may contribute to hypokalemia, including any residual diuretic use. 8

  • Unlike peritoneal dialysis patients (who frequently develop hypokalemia due to glucose-mediated intracellular potassium shift), hemodialysis patients more commonly experience hyperkalemia, making true hypokalemia an important finding requiring investigation. 9

Common Pitfalls to Avoid

  • Do not use high dialysate sodium (≥140 mEq/L) thinking it will help with hypotension, as this creates a vicious cycle of thirst, weight gain, and worsening hypertension. 6, 7

  • Do not aggressively correct hyponatremia in the first dialysis session—the risk of osmotic demyelination syndrome outweighs the urgency of correction unless the patient is severely symptomatic. 1, 2

  • Do not overlook residual kidney function preservation, as this is one of the most important predictors of patient survival and allows better fluid and electrolyte balance. 6

References

Guideline

Management of Hyponatremia in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dialysate Sodium Management for ESRD Patients with Severe Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014

Research

Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypotension During Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.